Navigation Links
Nasal Anthrax Vaccine Proves Effective in Animal Study
Date:8/31/2007

Though not ready for humans, it offered immunity for at least 6 months

FRIDAY, Aug. 31 (HealthDay News) -- An experimental nasal anthrax vaccine proved highly effective in tests in mice and guinea pigs, a University of Michigan Medical School study shows.

After it was placed inside the animals' noses, the vaccine triggered a strong immune response. All immunized guinea pigs survived after they received injections of 1,000 times the lethal dose of anthrax spores. All unprotected guinea pigs died.

From 40 percent to 70 percent of immunized animals survived after large doses of anthrax spores were placed directly in their nasal tissue.

In these animal experiments, there have been no significant side effects, and the vaccine has produced effective immunity for at least six months, the study said.

The nasal vaccine features tiny soybean oil droplets that are small enough to carry an anthrax protein inside the nasal membrane. Immune system cells then react to the anthrax protein and prime the entire immune system to attack anthrax.

This nasal vaccine is easier and more effective than the current injectable vaccine, according to the researchers. The nasal vaccine is also easier to store and use in locations where there is no available refrigeration.

The next step is to test whether the vaccine produces immunity in primates. The researchers are also preparing plans for safety studies in humans.

The study was published in the August issue of Infection and Immunity.

More information

The U.S. Centers for Disease Control and Prevention has more about anthrax.



-- Robert Preidt



SOURCE: University of Michigan Health System, news release, August 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Nasal Spray Could Take Drugs Direct to Brain.
2. Nasal Spray Could Take Drugs Directly to Brain
3. Nasal Spray Beats Antihistamine
4. Nasal sprays used for other ailments!
5. Chronic Sinusitis May Be Related To Nasal Mucus
6. Stress – Buster : Hormonal Nasal Spra
7. CDC To Conduct Pre-clinical Trails Of BioDiems Intranasal Bird Flu Vaccine
8. Cluster Headaches Can Be Treated By Nasal Spray
9. Nasal Plastic Surgery Improves Airway Function
10. Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404
11. Patients Dissatisfied Following Closed Reduction Of Nasal Fractures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... Arizona (PRWEB) , ... April 29, 2016 , ... ... Healing and Spiritual Awakening , announces the addition Onnit brand Alpha BRAIN and ... The addition of Onnit brain and mood optimization products to the store is ...
(Date:4/29/2016)... Springs, California (PRWEB) , ... April 29, 2016 ... ... lies at the heart of our nation’s productivity, stability, even security. Most importantly, ... for their organizations. , Then why are American workers so unhappy? , Just ...
(Date:4/29/2016)... ... April 29, 2016 , ... Conditions were ideal for Global Lyme Alliance’s ... Sunday, with sunny skies, a light breeze and temperatures in the 60s. Over 400 ... 5k Run and Walk and 1-mile walk were held to increase awareness about ...
(Date:4/29/2016)... Texas (PRWEB) , ... April 29, 2016 , ... Spine ... neck pain, is proud to announce one of their physicians has been invited to ... Family Physicians (Texas ACOFP) Family Practice Review conference on April 30, 2016. , ...
(Date:4/29/2016)... ... April 29, 2016 , ... World Patent Marketing , ... exercise invention which aids in proper muscle development. , "The Gym & Exercise ... Director of World Patent Marketing. "Globalization has threatened the future growth of the ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016 Research and Markets ... Surgery Products Market 2016-2020" report to their offering. ... The global plastic surgery products market is ... the period 2016-2020. , ,The growing adoption of laser ... growth of the market. Lasers are used to treat ...
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... , April 28, 2016 TapImmune,Inc. ... of innovative peptide and gene-based immunotherapeutics and vaccines for the ... be presenting at the 3rd Annual Growth Capital Expo ... th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... on Wednesday, May 4 th by Dr. John ...
Breaking Medicine Technology: